<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Allergan</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Allergan">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Allergan</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Allergan plc</b> is an Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.<span class="mw-ref" id="cite_ref-10K_1-1"><a href="#cite_note-10K-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-wsj1_2-0"><a href="#cite_note-wsj1-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The company is the maker of Botox.<span class="mw-ref" id="cite_ref-10K_1-2"><a href="#cite_note-10K-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>



<table class="infobox vcard" style="width:22em"><caption class="fn org">Allergan plc</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Allergan_plc_logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Allergan_plc_logo.svg.png" data-file-width="512" data-file-height="114" data-file-type="drawing" height="49" width="220"></figure-inline></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Type</div></th><td class="category" style="line-height: 1.35em;">Subsidiary of AbbVie Inc.</td></tr><tr><th scope="row" style="padding-right: 0.5em;">ISIN</th><td style="line-height: 1.35em;"><span class=" nourlexpansion"><a href="javascript:if(confirm('https://iw.toolforge.org/isin/?language=en&isin=IE00BY9D5467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://iw.toolforge.org/isin/?language=en&isin=IE00BY9D5467'" tppabs="https://iw.toolforge.org/isin/?language=en&isin=IE00BY9D5467" class="external text external">IE00BY9D5467<span>&nbsp;</span><figure-inline class="mw-valign-text-top"></figure-inline></a><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;">Pharmaceuticals</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Predecessors</th><td style="line-height: 1.35em;">Allergan, Inc. and Actavis before the 2015 Irish tax inversion and merger</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">May<span>&nbsp;</span>16, 2013<span style="display:none"><span>&nbsp;</span>(<span class="bday dtstart published updated">2013-05-16</span>)</span> upon the combination of Allergan Finance, LLC (Actavis) &amp; Warner Chilcott<br>March<span>&nbsp;</span>17, 2015<span style="display:none"><span>&nbsp;</span>(<span class="bday dtstart published updated">2015-03-17</span>)</span> renamed to Allergan Plc upon the merger of Allergan, Inc and Actavis</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founder</th><td class="agent" style="line-height: 1.35em;">Allen Chao<span>&nbsp;</span><figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;">Clonshaugh Business &amp; Technology Park, Coolock, D17 E400, <div style="display: inline;" class="locality">Dublin</div>, <div style="display: inline;" class="country-name">Ireland</div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of locations</div></th><td style="line-height: 1.35em;">40 manufacturing facilities, 27 global R&amp;D centres and marketing/sales facilities worldwide.</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height: 1.35em;">~100 countries</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;">Branded pharmaceuticals</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><figure-inline><span><img src="../I/m/Increase2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Increase2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"></span></figure-inline> $16.089 billion<span>&nbsp;</span>(2019)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Net income</div></th><td style="line-height: 1.35em;"><figure-inline><span><img src="../I/m/Decrease2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Decrease2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"></span></figure-inline> -$5.142 billion<span>&nbsp;</span>(2018)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap">Total assets</span></th><td style="line-height: 1.35em;"><figure-inline><span><img src="../I/m/Decrease2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Decrease2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"></span></figure-inline> $94.699 billion<span>&nbsp;</span>(2019)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap">Total equity</span></th><td style="line-height: 1.35em;"><figure-inline><span><img src="../I/m/Decrease2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Decrease2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"></span></figure-inline> $58.195 billion<span>&nbsp;</span>(2019)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">17,800<span>&nbsp;</span>(2018)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Parent</th><td style="line-height: 1.35em;">AbbVie Inc.</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a href="javascript:if(confirm('https://www.allergan.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.allergan.com/'" tppabs="https://www.allergan.com/" class="external text external">www<wbr>.allergan<wbr>.com</a></span></td></tr><tr><td colspan="2" style="text-align:center;line-height: 1.35em;"><b>Footnotes<span>&nbsp;</span>/<span> </span>references</b><br><span class="mw-ref" id="cite_ref-10K_1-0"><a href="#cite_note-10K-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr></tbody></table>
<p>Allergan plc was formed in March 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name.<span class="mw-ref" id="cite_ref-activis_deals_4-0"><a href="#cite_note-activis_deals-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>In 2016, Allergan sold its generic business, Actavis, to Teva for $40.5 billion.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. The merged company would be domiciled in the U.S. for tax purposes.<span class="mw-ref" id="cite_ref-abbvieguardian_7-0"><a href="#cite_note-abbvieguardian-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-abbviebloomberg_8-0"><a href="#cite_note-abbviebloomberg-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    

<p>Allergan plc was created from the 2015 merger and Irish corporate tax inversion of two companies, Irish-based Actavis plc and U.S.-based Allergan, Inc.<span class="mw-ref" id="cite_ref-:0_9-0"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    <details data-level="4" open="">
    <summary class="section-heading"><h4 id="Allergan,_Inc.">Allergan, Inc.</h4></summary>
    

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Allergan,_inc_logo.png" tppabs="https://ptable.com/wiki/compounds/I/m/Allergan%2C_inc_logo.png" data-file-width="707" data-file-height="141" data-file-type="bitmap" height="44" width="220"><div class="thumbcaption" style="text-align: left">Logo used for the original Allergan until the merger with Actavis in 2015</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Allergan_headquarters.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Allergan_headquarters.jpg" data-file-width="2776" data-file-height="1956" data-file-type="bitmap" height="155" width="220"><div class="thumbcaption" style="text-align: left">Allergan, Inc. headquarters in Irvine</div></div></div>

<p>In 1948, pharmacist Gavin S. Herbert founded Allergan Pharmaceuticals, Inc.<span class="mw-ref" id="cite_ref-:0_9-1"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> In 1970, Allergan, Inc. became a public company via an initial public offering.<span class="mw-ref" id="cite_ref-:0_9-2"><a href="#cite_note-:0-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> In 1977, Allergan announced plans to build a factory in Westport, Ireland.<span class="mw-ref" id="cite_ref-:1_10-0"><a href="#cite_note-:1-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>In 1980, it was acquired by SmithKline Corporation for $259 million<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> and was later spun-off by SmithKline Beecham in 1989.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In 1989, Allergan opened a manufacturing plant in Waco, Texas to manufacture eye care products.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p> 

<p>In 1991, Allergan acquired the company Oculinum which manufactured products for eye muscle disorders.<span class="mw-ref" id="cite_ref-:2_14-0"><a href="#cite_note-:2-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Following the acquisition, the product was renamed Botox.<span class="mw-ref" id="cite_ref-:2_14-1"><a href="#cite_note-:2-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> In 1996, Allergan received FDA approval for <a href="Brimonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brimonidine" title="Brimonidine">Alphagan</a> ophthalmic solution for open-angle glaucoma and ocular hypertension.<span class="mw-ref" id="cite_ref-:4_17-0"><a href="#cite_note-:4-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> In 1998, Allergan established The Allergan Foundation, a private US-based charitable foundation.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>In 2005, Allergan acquired Inamed which had a licensing agreement with Corneal Group Laboratoires for Juvederm products.<span class="mw-ref" id="cite_ref-:5_19-0"><a href="#cite_note-:5-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> In 2006, Allergan gained rights to Juvederm products.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Actavis_plc">Actavis plc</h4></summary>
    
<p>In the spring of 1983, colleagues Allen Chao and David Hsia formed Watson Pharmaceuticals, a drug development in Libertyville, Illinois.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> In late fall of 1983, the company moved to Corona, California and began to develop and manufacture generic pharmaceuticals.<span class="mw-ref" id="cite_ref-:3_25-0"><a href="#cite_note-:3-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> In February 1993, the company became a public company via an initial public offering.<span class="mw-ref" id="cite_ref-:3_25-1"><a href="#cite_note-:3-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>In 2011, the company moved its corporate headquarters from Corona, California to Parsippany-Troy Hills, New Jersey.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> On October 31, 2012, Watson acquired Actavis for €<span>4.25 billion</span> and took the Actavis name.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> In 2013, Actavis acquired Irish–registered Warner Chilcott for $5 billion and used the transaction to execute a corporate tax inversion to Ireland.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> In 2014, Actavis acquired Forest Laboratories for $25 billion.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Acquisition_by_Actavis_plc_(2015–2019)">Acquisition by Actavis plc (2015–2019)</h3></summary>
    


<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Allergan_Headquarters_in_Ireland_(Clonsaugh_Park,_Coolock,_Dublin).jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Allergan_Headquarters_in_Ireland_(Clonsaugh_Park%2C_Coolock%2C_Dublin).jpg" data-file-width="260" data-file-height="194" data-file-type="bitmap" height="164" width="220"><div class="thumbcaption" style="text-align: left">Allergan plc headquarters in Ireland</div></div></div>

<p>In 2015, Irish–based Actavis plc acquired U.S.–based Allergan, Inc. for $70 billion, and in effect redomiciled Allergan to Ireland in a corporate tax inversion.<span class="mw-ref" id="cite_ref-activis_deals_4-1"><a href="#cite_note-activis_deals-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Actavis CEO Brent Saunders became the CEO of the combined company.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> In June 2015, the company took the Allergan name.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> At the time, over 85% of the combined sales of the post-merger Allergan plc were from the U.S. healthcare system.</p>

<p>As of 2020, the company operated four facilities in Ireland.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-:1_10-1"><a href="#cite_note-:1-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="2015">2015</h4></summary>
    

<p>On July 7, 2015, the company acquired the rights to the late stage CGRP migraine portfolio of Merck &amp; Co, as well as two experimental drugs for an upfront payment of $250 million.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Later that summer, the company acquired Oculeve for $125 million<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> and Naurex for an upfront payment of $560 million.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> In October 2015, the company acquired AqueSys, developer of ocular implants for an initial payment of $300 million,<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> along with Kythera Biopharmaceuticals, a company focused on the medical aesthetics market, for $2.1 billion.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p> 

<p>In late 2015, the company announced the acquisition of Northwood Medical Innovation, the developer of earFold.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> On November 25, 2015, the company announced it would partner with Rugen Therapeutic to develop new therapies for autism spectrum disorder and obsessive compulsive disorder.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Abandon_Merger_with_Pfizer">Abandon Merger with Pfizer</h4></summary>
    
<p>On November 23, 2015, Allergan and Pfizer announced their intention to merge in a $160 billion transaction.<span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> On April 5, 2016, after the Obama administration announced its plan to ban tax inversions, Pfizer terminated the acquisition and paid Allergan a $150 million breakup fee.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="2016">2016</h4></summary>
    
<p>In April 2016, the company announced it would partner with Heptares Therapeutics to develop a subtype-selective muscarinic agonists for Alzheimer's disease<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> and announced the acquisition of Topokine Therapeutics, gaining the phase IIb/III compound XAF5 - a treatment for dermatochalasis.<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p> 

<p>In August 2016, Allergan plc sold its generic drugs business to Teva Pharmaceutical Industries in a $40.5 billion deal<span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> and announced the acquisition of ForSight VISION5 for more than $95 million.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p> 

<p>In September 2016, CEO Saunders announced what he called a social contract to limit prices on the company's medications.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> That same month, the company acquired RetroSense Therapeutics for more than $60 million,<span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> announced the acquisition of Tobira Therapeutics for approximately $1.7 billion<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> and, a day later, the acquisition of Akarna Therapeutics for $50 million.<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span></p> 

<p>In October 2016, the company sold Anda, its generic drug distribution business, to Teva for $500 million<span class="mw-ref" id="cite_ref-:6_58-0"><a href="#cite_note-:6-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-59"><a href="#cite_note-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> and acquired Vitae Pharmaceuticals, focused on dermatology treatments, for $639 million.<span class="mw-ref" id="cite_ref-:6_58-1"><a href="#cite_note-:6-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> That same month, the company announced it would acquire Motus Therapeutics, a developer of treatments for gastrointestinal disorders, for $200 million.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> On November 22, 2016, the company acquired Chase Pharmaceuticals for $125 million.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-64"><a href="#cite_note-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="2017-2020">2017-2020</h4></summary>
    
<p>In 2017, the company acquired LifeCell, a specialist in regenerative medicine, for $2.9 billion and Zeltique Aesthetics, maker of CoolSculpting, for $2.4 billion.<span class="mw-ref" id="cite_ref-:7_65-0"><a href="#cite_note-:7-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-68"><a href="#cite_note-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> On June 7, the company announced the acquisition of Keller Medical, a company that manufactures devices for use during breast augmentation surgery.<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> On December 12, the company announced the acquisition of Repros Therapeutics, a developer of drugs for reproductive system diseases.<span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>In September 2018, Allergan acquired the aesthetic company, Bonti, for $195 million.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span><span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>

<p>In March 2019, the company acquired Envy Medical, Inc.<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> As of 2019, Allergan's Botox product had annual sales of nearly $4 billion.<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>

<p>In 2018, along with several other drug manufacturers and distributors, the company was sued by several municipalities and states in the U.S. due to the manufacture of opioids, which have been abused in what has been referred to as the opioid epidemic.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Acquisition_by_AbbVie_Inc._(2019-present)">Acquisition by AbbVie Inc. (2019-present)</h3></summary>
    

<p>In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion,<span class="mw-ref" id="cite_ref-abbvieguardian_7-1"><a href="#cite_note-abbvieguardian-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> which would return Allergan to the U.S. for tax purposes.<span class="mw-ref" id="cite_ref-abbviebloomberg_8-1"><a href="#cite_note-abbviebloomberg-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> On the announcement of the transaction, Abbvie disclosed that its 2019 net effective tax rate was 9%, but that post the acquisition, the Group's effective tax rate would rise to 13%. The merger is expected to close in 2020.<span class="mw-ref" id="cite_ref-abbviebloomberg_8-2"><a href="#cite_note-abbviebloomberg-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>On May 8, 2020, AbbVie completed its acquisition of Allergan.</p>
<p>
<br></p>

</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Acquisition_history">Acquisition history</h3></summary>
    
<div class="mw-collapsible mw-collapsible-leftside-toggle mw-collapsed " style="box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:none;"><div style="font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:left;;background:white;">Illustration of the company's mergers, acquisitions, spin-offs and historical predecessors</div><div class="mw-collapsible-content" style="background:transparent;text-align:left;;">
<style data-mw-deduplicate="TemplateStyles:r935768785">.mw-parser-output table.clade{border-spacing:0;margin:0;font-size:100%;line-height:100%;border-collapse:separate;width:auto}.mw-parser-output table.clade table.clade{width:100%}.mw-parser-output table.clade td.clade-label{width:0.7em;padding:0 0.15em;vertical-align:bottom;text-align:center;border-left:1px solid;border-bottom:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-fixed-width{overflow:hidden;text-overflow:ellipsis}.mw-parser-output table.clade td.clade-fixed-width:hover{overflow:visible}.mw-parser-output table.clade td.clade-label.first{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-label.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-slabel{padding:0 0.15em;vertical-align:top;text-align:center;border-left:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-slabel:hover{overflow:visible}.mw-parser-output table.clade td.clade-slabel.last{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-slabel.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-bar{vertical-align:middle;text-align:left;padding:0 0.5em;position:relative}.mw-parser-output table.clade td.clade-bar.reverse{text-align:right;position:relative}.mw-parser-output table.clade td.clade-leaf{border:0;padding:0;text-align:left}.mw-parser-output table.clade td.clade-leafR{border:0;padding:0;text-align:right}.mw-parser-output table.clade td.clade-leaf.reverse{text-align:right}.mw-parser-output table.clade:hover span.linkA{background-color:yellow}.mw-parser-output table.clade:hover span.linkB{background-color:green}</style>
<table class="clade" style="font-size:90%;line-height:110%">

<tbody><tr>
<td class="clade-label first" style="border-left:none;border-right:none;border-bottom:0px solid;"><div style="display:inline;" class="nowrap"><span style="font-size:100%;"><b>Allergan, plc</b><br><small>(formerly known as Actavis until June 2015<br>when it adopted Allergan's name. Acquired by Abbvie June 2019)</small></span></div></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first">Actavis&nbsp;plc</td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Auden Mckenzie Holdings Limited<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Durata Therapeutics <br><small>(Acq 2014)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Silom Medical Company<br><small>(Acq 2014)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first">Forest&nbsp;Laboratories<br><small>(Acq<span>&nbsp;</span>2014)</small></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first">Aptalis&nbsp;Pharma</td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Axcan Pharma</p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Eurand Pharmaceuticals</p></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Furiex Pharmaceuticals Inc<br><small>(Acq 2014)</small></p></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Galen<br><small>(Acq 2013)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Uteron Pharma, S.A. <br><small>(Acq 2013)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Warner Chilcott Plc<br><small>(Acq 2000)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Procter &amp; Gamble<br><small>(Prescription drug div, Acq 2009)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Watson Pharmaceuticals</p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Andrx Corporation<br><small>(Acq 2006)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Arrow Group<br><small>(Acq 2009)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Eden Biodesign<br><small></small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Specifar Pharmaceuticals S.A.<br><small>(Acq 2011)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Ascent Pharmahealth Ltd<br><small>(Acq 2012)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span>&nbsp;</span></td>
<td rowspan="2" class="clade-leaf">
<p>Actavis Group<br><small>(Acq 2012)</small></p></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label">Allergan,&nbsp;inc</td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Kythera Biopharmaceuticals<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>MAP Pharmaceuticals Inc<br><small>(Acq 2013)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Inamed Corporation<br><small>(Acq 2006)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Allergan<br><small>(Advanced Medical Optics spun off in 2006)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Janssen-Ortho<br><small>Spun off in 2006</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Abbott Laboratories<br><small>Acq 2007</small></p></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label">Allergan,&nbsp;plc</td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Envy Medical, Inc.<br><small>(Acq 2019)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Repros Therapeutics<br><small>(Acq 2017)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Keller Medical, Inc<br><small>(Acq 2017)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Zeltiq Aesthetics Inc.<br><small>(Acq 2017)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>LifeCell<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Chase Pharmaceuticals<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Motus Therapeutics<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Akarna Therapeutics<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>RetroSense Therapeutics<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>ForSight VISION5<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Tobira Therapeutics<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Vitae Pharmaceuticals, Inc<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Topokine Therapeutics<br><small>(Acq 2016)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Northwood Medical Innovation Ltd<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>AqueSys<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Naurex Inc<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel"><span> </span></td></tr>

<tr>
<td class="clade-label"><span> </span></td>
<td rowspan="2" class="clade-leaf">

<table class="clade">

<tbody><tr>
<td class="clade-label first"><span> </span></td>
<td rowspan="2" class="clade-leaf">
<p>Oculeve, Inc<br><small>(Acq 2015)</small></p></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last"><span> </span></td></tr>
</tbody></table></td></tr>
<tr>
<td class="clade-slabel last" style="border-right:none;border-left:none;"><span> </span></td></tr>
</tbody></table>

</div></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Products">Products</h2></summary>
    
<p>Allergan acquires, develops, manufactures and markets branded products in four therapeutic areas: medical aesthetics, eye care, central nervous system, and gastroenterology. The company manufactures several pharmaceutical products including Botox (<a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">botulinum toxin</a>), Juvederm (injectable filler), CoolSculpting (Cryolipolysis), Alphagan (brimonidine), Vraylar (cariprazine HCI), Linzess (linaclotide),<span class="mw-ref" id="cite_ref-10K_1-3"><a href="#cite_note-10K-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> and Ubrelvy (ubrogepant).<span class="mw-ref" id="cite_ref-:2_14-2"><a href="#cite_note-:2-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-:5_19-1"><a href="#cite_note-:5-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-:7_65-1"><a href="#cite_note-:7-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-:4_17-1"><a href="#cite_note-:4-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Biotech and pharmaceutical companies in the New York metropolitan area</li>
<li>The St. Regis Mohawk Tribe and Restasis patent</li>
<li>Corporate tax inversion</li>
<li>Ireland as a tax haven</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-10K-1"> <span id="mw-reference-text-cite_note-10K-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm" class="external text external">"Allergan plc 2018 Form 10-K Annual Report"</a>. <i>U.S. Securities and Exchange Commission</i>.</cite></span></li><li id="cite_note-wsj1-2"> <span id="mw-reference-text-cite_note-wsj1-2" class="mw-reference-text"><cite id="CITEREFRockoffTrentmann2018" class="citation news cs1">Rockoff, Jonathan D.; Trentmann, Nina (11 February 2018). <a href="javascript:if(confirm('https://www.wsj.com/articles/new-tax-law-haunts-companies-that-did-inversion-deals-1518350401  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/new-tax-law-haunts-companies-that-did-inversion-deals-1518350401'" tppabs="https://www.wsj.com/articles/new-tax-law-haunts-companies-that-did-inversion-deals-1518350401" class="external text external">"New Tax Law Haunts Inversion Deals"</a>. <i>The Wall Street Journal</i>. <q>Similarly, Allergan, a drugmaker that moved its headquarters to Ireland after a 2013 acquisition but gets about 80% of revenue in the U.S., expects the loss of deductions on intercompany loans will largely be balanced out by lower taxes on its U.S. sales.</q></cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFRockoff2018" class="citation news cs1">Rockoff, Jonathan D. (2018-05-30). <a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-to-sell-businesses-in-bid-to-appease-shareholders-1527697604  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-to-sell-businesses-in-bid-to-appease-shareholders-1527697604'" tppabs="https://www.wsj.com/articles/allergan-to-sell-businesses-in-bid-to-appease-shareholders-1527697604" class="external text external">"Allergan To Sell Businesses in Bid To Appease Shareholders"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-activis_deals-4"> <span id="mw-reference-text-cite_note-activis_deals-4" class="mw-reference-text"><cite class="citation magazine cs1"><a href="javascript:if(confirm('http://fortune.com/2015/07/30/actavis-allergan-timeline/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://fortune.com/2015/07/30/actavis-allergan-timeline/'" tppabs="http://fortune.com/2015/07/30/actavis-allergan-timeline/" class="external text external">"From Actavis to Allergan: One pharma company's wild dealmaking journey"</a>. <i>Fortune</i>. 30 July 2015. <q>For a master class in mergers and acquisitions, one need only look at the company formerly known as Actavis. Now called Allergan, after its $70 billion acquisition of that maker of Botox last fall, the pharmaceutical firm has undertaken a dizzying series of deals in just the last few years, reinventing and renaming itself in a fashion that might make the artist formerly known as The Artist Formerly Known As Prince proud.</q></cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFHaggerty2015" class="citation news cs1">Haggerty, Neil (2015-06-15). <a href="javascript:if(confirm('https://www.wsj.com/articles/actavis-changes-name-to-allergan-after-deal-for-botox-maker-1434370774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/actavis-changes-name-to-allergan-after-deal-for-botox-maker-1434370774'" tppabs="https://www.wsj.com/articles/actavis-changes-name-to-allergan-after-deal-for-botox-maker-1434370774" class="external text external">"Actavis Changes Name to Allergan After Deal For Botox Maker"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://fortune.com/2016/03/16/teva-allergan-deal-delayed/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fortune.com/2016/03/16/teva-allergan-deal-delayed/'" tppabs="https://fortune.com/2016/03/16/teva-allergan-deal-delayed/" class="external text external">"Why Teva's $40 Billion Deal for Allergan's Generic Drugs Is Being Delayed"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-abbvieguardian-7"> <span id="mw-reference-text-cite_note-abbvieguardian-7" class="mw-reference-text"><cite id="CITEREFJulia_Kollewe2019" class="citation web cs1">Julia Kollewe (25 June 2019). <a href="javascript:if(confirm('https://www.theguardian.com/business/2019/jun/25/botox-maker-allergan-bought-by-us-drug-giant-abbvie-for-63bn  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/business/2019/jun/25/botox-maker-allergan-bought-by-us-drug-giant-abbvie-for-63bn'" tppabs="https://www.theguardian.com/business/2019/jun/25/botox-maker-allergan-bought-by-us-drug-giant-abbvie-for-63bn" class="external text external">"Botox maker Allergan bought by US drug giant for $63bn"</a>. <i>The Guardian</i><span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2019</span>.</cite></span></li><li id="cite_note-abbviebloomberg-8"> <span id="mw-reference-text-cite_note-abbviebloomberg-8" class="mw-reference-text"><cite id="CITEREFRebecca_SpaldingRiley_Griffin2019" class="citation web cs1">Rebecca Spalding; Riley Griffin (25 June 2019). <a href="javascript:if(confirm('https://www.bloomberg.com/news/articles/2019-06-25/abbvie-in-63-billion-deal-to-buy-botox-maker-allergan  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/news/articles/2019-06-25/abbvie-in-63-billion-deal-to-buy-botox-maker-allergan'" tppabs="https://www.bloomberg.com/news/articles/2019-06-25/abbvie-in-63-billion-deal-to-buy-botox-maker-allergan" class="external text external">"AbbVie Strikes $63 Billion Deal for Botox Maker Allergan"</a>. Bloomberg News<span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2019</span>. <q>The deal will return Allergan to the U.S., at least for tax purposes.</q></cite></span></li><li id="cite_note-:0-9"> <span id="mw-reference-text-cite_note-:0-9" class="mw-reference-text"><cite id="CITEREFRamsey" class="citation web cs1">Ramsey, Lydia. <a href="javascript:if(confirm('https://www.businessinsider.com/allergan-history-since-1948-founding-2015-11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.businessinsider.com/allergan-history-since-1948-founding-2015-11'" tppabs="https://www.businessinsider.com/allergan-history-since-1948-founding-2015-11" class="external text external">"How Allergan went from a tiny Los Angeles eye care company to the biggest takeover target of 2015"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-:1-10"> <span id="mw-reference-text-cite_note-:1-10" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://www.rte.ie/news/business/2020/0128/1111363-allergan-mayo-expansion/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rte.ie/news/business/2020/0128/1111363-allergan-mayo-expansion/'" tppabs="https://www.rte.ie/news/business/2020/0128/1111363-allergan-mayo-expansion/" class="external text external">"Allergan opens new €160m biologics plant in Westport"</a>. <i>rte.ie</i>. 2020-01-28.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFCommission1980" class="citation book cs1">Commission, United States Federal Trade (July 1980). <a href="javascript:if(confirm('https://books.google.com/books?id=ODLnFzyuy0QC&dq=Allergan+was+acquired+by+SmithKline+Corporation+1980&source=gbs_navlinks_s  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ODLnFzyuy0QC&dq=Allergan+was+acquired+by+SmithKline+Corporation+1980&source=gbs_navlinks_s'" tppabs="https://books.google.com/books?id=ODLnFzyuy0QC&dq=Allergan+was+acquired+by+SmithKline+Corporation+1980&source=gbs_navlinks_s" class="external text external"><i>Federal Trade Commission Decisions</i></a>. U.S. Government Printing Office.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFBerkman1989" class="citation news cs1">Berkman, Leslie (July 27, 1989). <a href="javascript:if(confirm('http://articles.latimes.com/1989-07-27/business/fi-352_1_smithkline-beckman  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://articles.latimes.com/1989-07-27/business/fi-352_1_smithkline-beckman'" tppabs="http://articles.latimes.com/1989-07-27/business/fi-352_1_smithkline-beckman" class="external text external">"Shareholders OK SmithKline Deal Spinning Off Beckman, Allergan"</a>. <i>Los Angeles Times</i>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFCopeland" class="citation web cs1">Copeland, Mike. <a href="javascript:if(confirm('https://www.wacotrib.com/business/allergan-with-waco-plant-could-be-sold-in-63-billion-deal/article_0a8f9024-dd1b-5b4e-8e06-9c74df0c83ad.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wacotrib.com/business/allergan-with-waco-plant-could-be-sold-in-63-billion-deal/article_0a8f9024-dd1b-5b4e-8e06-9c74df0c83ad.html'" tppabs="https://www.wacotrib.com/business/allergan-with-waco-plant-could-be-sold-in-63-billion-deal/article_0a8f9024-dd1b-5b4e-8e06-9c74df0c83ad.html" class="external text external">"Allergan, with Waco plant, could be sold in $63 billion deal"</a>. <i>WacoTrib.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-:2-14"> <span id="mw-reference-text-cite_note-:2-14" class="mw-reference-text"><cite id="CITEREFVara" class="citation web cs1">Vara, Vauhini. <a href="javascript:if(confirm('https://www.newyorker.com/business/currency/actavis-allergan-botox-sale  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.newyorker.com/business/currency/actavis-allergan-botox-sale'" tppabs="https://www.newyorker.com/business/currency/actavis-allergan-botox-sale" class="external text external">"Billions and Billions for Botox"</a>. <i>The New Yorker</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFAp1990" class="citation news cs1">Ap (1990-01-09). <a href="javascript:if(confirm('https://www.nytimes.com/1990/01/09/science/eye-drug-approved-by-fda.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1990/01/09/science/eye-drug-approved-by-fda.html'" tppabs="https://www.nytimes.com/1990/01/09/science/eye-drug-approved-by-fda.html" class="external text external">"Eye Drug Approved By F.D.A."</a> <i>The New York Times</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0362-4331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0362-4331'" tppabs="https://www.worldcat.org/issn/0362-4331" class="external text external">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFEditionJune_10Steinert" class="citation web cs1">Edition, Ocular Surgery News U. S.; June 10; Steinert, 2018April. <a href="javascript:if(confirm('https://www.healio.com/ophthalmology/neurosciences/news/print/ocular-surgery-news/%7Be495ae1c-de2c-42de-97dd-a95b0f0977cf%7D/taking-a-chance-on-botox-paid-off-for-allergan  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healio.com/ophthalmology/neurosciences/news/print/ocular-surgery-news/%7Be495ae1c-de2c-42de-97dd-a95b0f0977cf%7D/taking-a-chance-on-botox-paid-off-for-allergan'" tppabs="https://www.healio.com/ophthalmology/neurosciences/news/print/ocular-surgery-news/%7Be495ae1c-de2c-42de-97dd-a95b0f0977cf%7D/taking-a-chance-on-botox-paid-off-for-allergan" class="external text external">"Taking a chance on Botox paid off for Allergan"</a>. <i>www.healio.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-:4-17"> <span id="mw-reference-text-cite_note-:4-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf" class="external text external">"ALPHAGAN (brimonidine tartrate ophthalmic solution)"</a> <span class="cs1-format">(PDF)</span>. <i>fda.gov</i>. 2016.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.bizjournals.com/cincinnati/news/2019/04/15/allergen-discloses-economic-impact-of-cincinnati.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bizjournals.com/cincinnati/news/2019/04/15/allergen-discloses-economic-impact-of-cincinnati.html'" tppabs="https://www.bizjournals.com/cincinnati/news/2019/04/15/allergen-discloses-economic-impact-of-cincinnati.html" class="external text external">"Allergan discloses economic impact of Cincinnati plant"</a>. <i>www.bizjournals.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-:5-19"> <span id="mw-reference-text-cite_note-:5-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.latimes.com/archives/la-xpm-2005-dec-16-fi-calbriefs16.4-story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.latimes.com/archives/la-xpm-2005-dec-16-fi-calbriefs16.4-story.html'" tppabs="https://www.latimes.com/archives/la-xpm-2005-dec-16-fi-calbriefs16.4-story.html" class="external text external">"Inamed Says Board Approves Allergan Offer"</a>. <i>Los Angeles Times</i>. 2005-12-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFFebruary_22007" class="citation web cs1">February 2; 2007. <a href="javascript:if(confirm('https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Be58fefeb-b8d1-442b-a0b9-5d96e02df58c%7D/allergan-reports-158-increase-in-2006-eye-care-pharmaceutical-sales  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Be58fefeb-b8d1-442b-a0b9-5d96e02df58c%7D/allergan-reports-158-increase-in-2006-eye-care-pharmaceutical-sales'" tppabs="https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Be58fefeb-b8d1-442b-a0b9-5d96e02df58c%7D/allergan-reports-158-increase-in-2006-eye-care-pharmaceutical-sales" class="external text external">"Allergan reports 15.8% increase in 2006 eye care pharmaceutical sales"</a>. <i>www.healio.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: numeric names: authors list (link)</span></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/850693/000095013707003060/a27376e10vk.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/850693/000095013707003060/a27376e10vk.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/850693/000095013707003060/a27376e10vk.htm" class="external text external">"e10vk - Allergan, Inc"</a>. <i>www.sec.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.thepharmaletter.com/article/allergan-buys-groupe-corneal-for-217m  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thepharmaletter.com/article/allergan-buys-groupe-corneal-for-217m'" tppabs="https://www.thepharmaletter.com/article/allergan-buys-groupe-corneal-for-217m" class="external text external">"Allergan buys Groupe Corneal for $217M - Pharmaceutical industry news"</a>. <i>www.thepharmaletter.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.reuters.com/article/allergan-fda-dermalfiller-idUSL3N0DH34U20130430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/allergan-fda-dermalfiller-idUSL3N0DH34U20130430'" tppabs="https://www.reuters.com/article/allergan-fda-dermalfiller-idUSL3N0DH34U20130430" class="external text external">"FDA staff says Allergan's new dermal filler effective"</a>. <i>Reuters</i>. 2013-04-30<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFService" class="citation web cs1">Service, Purdue News. <a href="javascript:if(confirm('https://www.purdue.edu/newsroom/releases/2016/Q4/pharmaceutical-leader-and-purdue-alumnus-brings-expertise-to-purdue-based-contract-drug-manufacturing-organization.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.purdue.edu/newsroom/releases/2016/Q4/pharmaceutical-leader-and-purdue-alumnus-brings-expertise-to-purdue-based-contract-drug-manufacturing-organization.html'" tppabs="https://www.purdue.edu/newsroom/releases/2016/Q4/pharmaceutical-leader-and-purdue-alumnus-brings-expertise-to-purdue-based-contract-drug-manufacturing-organization.html" class="external text external">"Pharmaceutical leader and Purdue alumnus brings expertise to Purdue-based contract drug manufacturing organization"</a>. <i>www.purdue.edu</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-:3-25"> <span id="mw-reference-text-cite_note-:3-25" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.latimes.com/archives/la-xpm-1996-06-12-fi-14183-story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.latimes.com/archives/la-xpm-1996-06-12-fi-14183-story.html'" tppabs="https://www.latimes.com/archives/la-xpm-1996-06-12-fi-14183-story.html" class="external text external">"Prescription for Success<span>&nbsp;</span>: Drug Maker Watson Thrives in Crowded Generic Market"</a>. <i>Los Angeles Times</i>. 1996-06-12<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFTodd2012" class="citation news cs1">Todd, Susan (January 30, 2012). <a href="javascript:if(confirm('http://www.nj.com/business/index.ssf/2012/01/generic_drug_maker_watson_open.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nj.com/business/index.ssf/2012/01/generic_drug_maker_watson_open.html'" tppabs="http://www.nj.com/business/index.ssf/2012/01/generic_drug_maker_watson_open.html" class="external text external">"Generic drug maker Watson opening research operations in North Brunswick"</a>. <i>NJ.com</i>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pe.com/2014/01/02/industry-corona-pharmaceuticals-plant-to-focus-on-contraceptives-now/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pe.com/2014/01/02/industry-corona-pharmaceuticals-plant-to-focus-on-contraceptives-now/'" tppabs="https://www.pe.com/2014/01/02/industry-corona-pharmaceuticals-plant-to-focus-on-contraceptives-now/" class="external text external">"INDUSTRY: Corona pharmaceuticals plant to focus on contraceptives now"</a>. <i>Press Enterprise</i>. 2014-01-02<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.reuters.com/article/uk-watson-actavis-idUKBRE83O1B820120426  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/uk-watson-actavis-idUKBRE83O1B820120426'" tppabs="https://www.reuters.com/article/uk-watson-actavis-idUKBRE83O1B820120426" class="external text external">"Watson to buy Actavis for at least 4.25 billion euros"</a>. <i>Reuters</i>. 2012-04-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.ft.com/content/4d5df734-c147-11e2-9767-00144feab7de  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ft.com/content/4d5df734-c147-11e2-9767-00144feab7de'" tppabs="https://www.ft.com/content/4d5df734-c147-11e2-9767-00144feab7de" class="external text external">"Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal"</a>. <i>Financial Times</i>. 20 May 2013. <q>Actavis sought to fend off takeover threats by purchasing Dublin-based rival Warner Chilcott in a $5bn deal designed to turn it into the world’s third-largest generic drug company by sales. The agreed all-stock deal, worth $8.5bn including net debt, follows recent efforts by competitors including Valeant and Mylan to acquire Actavis. Analysts said the move could spark alternative bids for Actavis or Warner Chilcott at a time of rapid consolidation in the sector. [..] The transaction will also exploit tax savings through the creation of a new Irish holding company, cutting Actavis’ estimated 28 percent tax rate this year to 17 per cent and helping create annual synergies that the company said would exceed $400m.</q></cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFMattioli2014" class="citation news cs1">Mattioli, Dana (2014-11-17). <a href="javascript:if(confirm('https://www.wsj.com/articles/potential-actavis-allergan-deal-paves-way-for-tax-savings-1416183632  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/potential-actavis-allergan-deal-paves-way-for-tax-savings-1416183632'" tppabs="https://www.wsj.com/articles/potential-actavis-allergan-deal-paves-way-for-tax-savings-1416183632" class="external text external">"Actavis-Allergan Deal Paves Way for Tax Savings"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFCimilluca2014" class="citation news cs1">Cimilluca, Dana Mattioli, Jonathan D. Rockoff and Dana (2014-02-18). <a href="javascript:if(confirm('https://www.wsj.com/articles/actavis-to-buy-forest-labs-for-25-billion-1392725732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/actavis-to-buy-forest-labs-for-25-billion-1392725732'" tppabs="https://www.wsj.com/articles/actavis-to-buy-forest-labs-for-25-billion-1392725732" class="external text external">"Actavis Agrees to Buy Forest Labs for $25 Billion"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFStewart" class="citation web cs1">Stewart, Emily. <a href="javascript:if(confirm('https://www.thestreet.com/politics/as-treasury-moves-to-bring-back-inversions-here-are-seven-of-the-biggest-recent-deals-html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestreet.com/politics/as-treasury-moves-to-bring-back-inversions-here-are-seven-of-the-biggest-recent-deals-html'" tppabs="https://www.thestreet.com/politics/as-treasury-moves-to-bring-back-inversions-here-are-seven-of-the-biggest-recent-deals-html" class="external text external">"As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals"</a>. <i>TheStreet</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite class="citation web cs1">Ramsey, Lydia. <a href="javascript:if(confirm('https://www.businessinsider.com/history-of-botox-maker-allergan-2018-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.businessinsider.com/history-of-botox-maker-allergan-2018-6'" tppabs="https://www.businessinsider.com/history-of-botox-maker-allergan-2018-6" class="external text external">"Allergan started out as a tiny but beloved Southern California eye care firm before expanding to a $130 billion company. Here's how the Botox-maker fell out grace with investors and then became a takeover target"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/actavis-officially-changes-name-to-allergan-/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/actavis-officially-changes-name-to-allergan-/'" tppabs="https://www.biospace.com/article/actavis-officially-changes-name-to-allergan-/" class="external text external">"Actavis Officially Changes Name to Allergan"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.independent.ie/business/irish/allergan-launches-145m-botox-site-as-merger-nears-38905999.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.independent.ie/business/irish/allergan-launches-145m-botox-site-as-merger-nears-38905999.html'" tppabs="https://www.independent.ie/business/irish/allergan-launches-145m-botox-site-as-merger-nears-38905999.html" class="external text external">"Allergan launches €145m Botox site as merger nears"</a>. <i>independent</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-07</span></span>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFDulaney2015" class="citation news cs1">Dulaney, Chelsey (July 7, 2015). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-buys-rights-to-mercks-migraine-drugs-1436268370  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-buys-rights-to-mercks-migraine-drugs-1436268370'" tppabs="https://www.wsj.com/articles/allergan-buys-rights-to-mercks-migraine-drugs-1436268370" class="external text external">"Allergan Buys Rights to Merck's Migraine Drugs"</a></span>. <i>The Wall Street Journal</i>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicaldevice-network.com/news/newsallergan-medical-device-firm-oculeve-4644342/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicaldevice-network.com/news/newsallergan-medical-device-firm-oculeve-4644342/'" tppabs="https://www.medicaldevice-network.com/news/newsallergan-medical-device-firm-oculeve-4644342/" class="external text external">"Allergan buys medical device firm Oculeve for $125m"</a>. <i>Verdict Medical Devices</i>. 2015-08-10<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFStahl2015" class="citation news cs1">Stahl, George (2015-07-26). <a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-to-acquire-naurex-for-560-million-cash-1437918753  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-to-acquire-naurex-for-560-million-cash-1437918753'" tppabs="https://www.wsj.com/articles/allergan-to-acquire-naurex-for-560-million-cash-1437918753" class="external text external">"Allergan to Acquire Naurex for $560 Million Cash"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFSeptember_42015" class="citation web cs1">September 4; 2015. <a href="javascript:if(confirm('https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B0e1aa516-a3e9-43cb-ac4c-06018cdee89c%7D/allergan-to-acquire-aquesys  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B0e1aa516-a3e9-43cb-ac4c-06018cdee89c%7D/allergan-to-acquire-aquesys'" tppabs="https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B0e1aa516-a3e9-43cb-ac4c-06018cdee89c%7D/allergan-to-acquire-aquesys" class="external text external">"Allergan to acquire AqueSys"</a>. <i>www.healio.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: numeric names: authors list (link)</span></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFBray2015" class="citation news cs1">Bray, Chad (2015-06-17). <a href="javascript:if(confirm('https://www.nytimes.com/2015/06/18/business/dealbook/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2015/06/18/business/dealbook/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion.html'" tppabs="https://www.nytimes.com/2015/06/18/business/dealbook/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion.html" class="external text external">"Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion"</a>. <i>The New York Times</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0362-4331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0362-4331'" tppabs="https://www.worldcat.org/issn/0362-4331" class="external text external">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/1620602/000119312515335373/d95661d8k.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/1620602/000119312515335373/d95661d8k.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/1620602/000119312515335373/d95661d8k.htm" class="external text external">"Form 8-K - WARNER CHILCOTT LIMITED"</a>. <i>www.sec.gov</i>. October 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFNovember_52015" class="citation web cs1">November 5; 2015. <a href="javascript:if(confirm('https://www.healio.com/aesthetics/business-of-aesthetics/news/online/%7Be010b424-93d5-429a-919f-b24b948ef4f6%7D/allergan-agrees-to-acquire-earfold-device-for-correcting-prominent-ears  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healio.com/aesthetics/business-of-aesthetics/news/online/%7Be010b424-93d5-429a-919f-b24b948ef4f6%7D/allergan-agrees-to-acquire-earfold-device-for-correcting-prominent-ears'" tppabs="https://www.healio.com/aesthetics/business-of-aesthetics/news/online/%7Be010b424-93d5-429a-919f-b24b948ef4f6%7D/allergan-agrees-to-acquire-earfold-device-for-correcting-prominent-ears" class="external text external">"Allergan agrees to acquire earFold device for correcting prominent ears"</a>. <i>www.healio.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: numeric names: authors list (link)</span></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.thepharmaletter.com/article/allergan-and-rugen-therapeutics-team-up-on-autism-and-ocd-research  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thepharmaletter.com/article/allergan-and-rugen-therapeutics-team-up-on-autism-and-ocd-research'" tppabs="https://www.thepharmaletter.com/article/allergan-and-rugen-therapeutics-team-up-on-autism-and-ocd-research" class="external text external">"Allergan and Rugen Therapeutics team up on autism and OCD research"</a>. <i>www.thepharmaletter.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.bbc.co.uk/news/business-34900344  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bbc.co.uk/news/business-34900344'" tppabs="https://www.bbc.co.uk/news/business-34900344" class="external text external">"Pfizer seals $160bn Allergan deal to create drugs giant"</a>. <i>BBC News</i>. November 23, 2015.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFRockoff2016" class="citation news cs1">Rockoff, Jonathan (April 6, 2016). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/pfizer-walks-away-from-allergan-deal-1459939739  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/pfizer-walks-away-from-allergan-deal-1459939739'" tppabs="https://www.wsj.com/articles/pfizer-walks-away-from-allergan-deal-1459939739" class="external text external">"Pfizer Walks Away From Allergan Deal"</a></span>. <i>The Wall Street Journal</i>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFHoffman2016" class="citation news cs1">Hoffman, Richard Rubin and Liz (2016-04-05). <a href="javascript:if(confirm('https://www.wsj.com/articles/u-s-treasury-unveils-new-steps-to-limit-tax-inversions-1459803636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/u-s-treasury-unveils-new-steps-to-limit-tax-inversions-1459803636'" tppabs="https://www.wsj.com/articles/u-s-treasury-unveils-new-steps-to-limit-tax-inversions-1459803636" class="external text external">"New Rules on Tax Inversions Threaten Pfizer-Allergan Deal"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fiercebiotech.com/partnering/solo-again-allergan-strikes-a-3-3b-deal-on-heptares-alzheimer-s-portfolio  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fiercebiotech.com/partnering/solo-again-allergan-strikes-a-3-3b-deal-on-heptares-alzheimer-s-portfolio'" tppabs="https://www.fiercebiotech.com/partnering/solo-again-allergan-strikes-a-3-3b-deal-on-heptares-alzheimer-s-portfolio" class="external text external">"Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio"</a>. <i>FierceBiotech</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/1578845/000156459016027705/agn-10q_20160930.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/1578845/000156459016027705/agn-10q_20160930.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/1578845/000156459016027705/agn-10q_20160930.htm" class="external text external">"Form 10-Q - ALLERGAN PLC"</a>. September 30, 2016.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/allergan-makes-another-deal-bags-boston-s-topokine-for-85-million-/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/allergan-makes-another-deal-bags-boston-s-topokine-for-85-million-/'" tppabs="https://www.biospace.com/article/allergan-makes-another-deal-bags-boston-s-topokine-for-85-million-/" class="external text external">"Allergan Makes Another Deal, Bags Boston's Topokine for $85 Million+"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/818686/000119312518039076/d529462dex1066.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/818686/000119312518039076/d529462dex1066.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/818686/000119312518039076/d529462dex1066.htm" class="external text external">"EX-10.66 - SETTLEMENT AGREEMENT AND MUTUAL RELEASES"</a>. <i>www.sec.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.bizjournals.com/philadelphia/morning_roundup/2016/08/teva-buying-anda-for-500-million-actavis.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bizjournals.com/philadelphia/morning_roundup/2016/08/teva-buying-anda-for-500-million-actavis.html'" tppabs="https://www.bizjournals.com/philadelphia/morning_roundup/2016/08/teva-buying-anda-for-500-million-actavis.html" class="external text external">"Teva completes $40.5B Actavis deal, enters into $500M for generics distributor"</a>. <i>www.bizjournals.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFMcElhaney" class="citation web cs1">McElhaney, Alicia. <a href="javascript:if(confirm('https://www.thestreet.com/markets/mergers-and-acquisitions/allergan-scoops-up-yet-another-biotech-company-13870974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestreet.com/markets/mergers-and-acquisitions/allergan-scoops-up-yet-another-biotech-company-13870974'" tppabs="https://www.thestreet.com/markets/mergers-and-acquisitions/allergan-scoops-up-yet-another-biotech-company-13870974" class="external text external">"Allergan scoops up yet another biotech company"</a>. <i>TheStreet</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.lifescienceleader.com/doc/behind-the-scenes-of-allergan-s-social-contract-0001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.lifescienceleader.com/doc/behind-the-scenes-of-allergan-s-social-contract-0001'" tppabs="https://www.lifescienceleader.com/doc/behind-the-scenes-of-allergan-s-social-contract-0001" class="external text external">"Behind The Scenes Of Allergan's Social Contract"</a>. <i>www.lifescienceleader.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://fortune.com/2016/09/06/allergan-drug-price-hike-promise-saunders/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fortune.com/2016/09/06/allergan-drug-price-hike-promise-saunders/'" tppabs="https://fortune.com/2016/09/06/allergan-drug-price-hike-promise-saunders/" class="external text external">"Allergan CEO Saunders Promises Responsible Drug Prices in 'Contract<span class="cs1-kern-right">'</span>"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFSeptember_72016" class="citation web cs1">September 7; 2016. <a href="javascript:if(confirm('https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bf11781cf-2782-4097-b3ff-b03fe7da8ec3%7D/allergan-acquires-retrosense-therapeutics  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bf11781cf-2782-4097-b3ff-b03fe7da8ec3%7D/allergan-acquires-retrosense-therapeutics'" tppabs="https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bf11781cf-2782-4097-b3ff-b03fe7da8ec3%7D/allergan-acquires-retrosense-therapeutics" class="external text external">"Allergan acquires RetroSense Therapeutics"</a>. <i>www.healio.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: numeric names: authors list (link)</span></span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite id="CITEREFStynes2016" class="citation news cs1">Stynes, Tess (September 20, 2016). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639'" tppabs="https://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639" class="external text external">"Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal"</a></span>. <i>The Wall Street Journal</i>.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite class="citation news cs1">Stynes, Tess (September 21, 2016). <span class="cs1-lock-subscription"><a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-to-acquire-u-k-s-akarna-therapeutics-1474456238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-to-acquire-u-k-s-akarna-therapeutics-1474456238'" tppabs="https://www.wsj.com/articles/allergan-to-acquire-u-k-s-akarna-therapeutics-1474456238" class="external text external">"Allergan to Acquire U.K.'s Akarna Therapeutics"</a></span>. <i>The Wall Street Journal</i>.</cite></span></li><li id="cite_note-:6-58"> <span id="mw-reference-text-cite_note-:6-58" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/1578845/000156459019003111/agn-10k_20181231.htm" class="external text external">"FORM 10-K-ALLERGAN PLC - WARNER CHILCOTT LIMITED"</a>. December 2018.</cite></span></li><li id="cite_note-59"> <span id="mw-reference-text-cite_note-59" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.reuters.com/article/us-allergan-m-a-teva-pharm-ind-idUSKCN10E1NE  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/us-allergan-m-a-teva-pharm-ind-idUSKCN10E1NE'" tppabs="https://www.reuters.com/article/us-allergan-m-a-teva-pharm-ind-idUSKCN10E1NE" class="external text external">"Allergan to sell Anda drug distribution business to Teva"</a>. <i>Reuters</i>. 2016-08-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFHufford2016" class="citation news cs1">Hufford, Austen (2016-09-14). <a href="javascript:if(confirm('https://www.wsj.com/articles/allergan-to-buy-vitae-pharmaceuticals-for-639-million-1473857881  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wsj.com/articles/allergan-to-buy-vitae-pharmaceuticals-for-639-million-1473857881'" tppabs="https://www.wsj.com/articles/allergan-to-buy-vitae-pharmaceuticals-for-639-million-1473857881" class="external text external">"Allergan to Buy Vitae Pharmaceuticals for $639 Million"</a>. <i>Wall Street Journal</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-9660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-9660'" tppabs="https://www.worldcat.org/issn/0099-9660" class="external text external">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFhttp://fyra.io" class="citation web cs1"><a href="javascript:if(confirm('http://fyra.io/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://fyra.io/'" tppabs="http://fyra.io/" class="external free external">http://fyra.io</a>. <a href="javascript:if(confirm('https://practicaldermatology.com/news/allergan-completes-vitae-tender-offer  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://practicaldermatology.com/news/allergan-completes-vitae-tender-offer'" tppabs="https://practicaldermatology.com/news/allergan-completes-vitae-tender-offer" class="external text external">"Allergan Completes Vitae Tender Offer"</a>. <i>Practical Dermatology</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.bizjournals.com/boston/news/2016/10/27/allergan-to-acquire-boston-drug-company-for-200m.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bizjournals.com/boston/news/2016/10/27/allergan-to-acquire-boston-drug-company-for-200m.html'" tppabs="https://www.bizjournals.com/boston/news/2016/10/27/allergan-to-acquire-boston-drug-company-for-200m.html" class="external text external">"Allergan to acquire Boston drug company for $200M"</a>. <i>www.bizjournals.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.businessinsider.com/r-brief-allergan-completes-acquisition-of-chase-pharmaceuticals-2016-11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.businessinsider.com/r-brief-allergan-completes-acquisition-of-chase-pharmaceuticals-2016-11'" tppabs="https://www.businessinsider.com/r-brief-allergan-completes-acquisition-of-chase-pharmaceuticals-2016-11" class="external text external">"BRIEF-Allergan completes acquisition of Chase Pharmaceuticals"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-64"> <span id="mw-reference-text-cite_note-64" class="mw-reference-text"><cite id="CITEREFMoney2016" class="citation web cs1">Money, Real (2016-11-25). <a href="javascript:if(confirm('https://realmoney.thestreet.com/articles/11/25/2016/allergan-could-pay-1-billion-chase-pharma  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://realmoney.thestreet.com/articles/11/25/2016/allergan-could-pay-1-billion-chase-pharma'" tppabs="https://realmoney.thestreet.com/articles/11/25/2016/allergan-could-pay-1-billion-chase-pharma" class="external text external">"Allergan could pay $1 billion for chase pharma"</a>. <i>RealMoney</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-:7-65"> <span id="mw-reference-text-cite_note-:7-65" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.reuters.com/article/us-zeltiq-m-a-allergan-idUSKBN15S1G1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/us-zeltiq-m-a-allergan-idUSKBN15S1G1'" tppabs="https://www.reuters.com/article/us-zeltiq-m-a-allergan-idUSKBN15S1G1" class="external text external">"Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion"</a>. <i>Reuters</i>. 2017-02-13<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.spglobal.com/marketintelligence/en/news-insights/trending/x-7xp_tmgbvnydmvhxyjra2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.spglobal.com/marketintelligence/en/news-insights/trending/x-7xp_tmgbvnydmvhxyjra2'" tppabs="https://www.spglobal.com/marketintelligence/en/news-insights/trending/x-7xp_tmgbvnydmvhxyjra2" class="external text external">"Allergan completes $2.9B LifeCell acquisition"</a>. <i>www.spglobal.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://fortune.com/2017/02/13/allergan-zeltiq-acquisition/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fortune.com/2017/02/13/allergan-zeltiq-acquisition/'" tppabs="https://fortune.com/2017/02/13/allergan-zeltiq-acquisition/" class="external text external">"Allergan Will Buy Zeltiq for $2.48 Billion"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-68"> <span id="mw-reference-text-cite_note-68" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.businessinsider.com/r-brief-allergan-completes-zeltiq-acquisition-2017-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.businessinsider.com/r-brief-allergan-completes-zeltiq-acquisition-2017-4'" tppabs="https://www.businessinsider.com/r-brief-allergan-completes-zeltiq-acquisition-2017-4" class="external text external">"BRIEF-Allergan completes Zeltiq acquisition"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.foxbusiness.com/markets/allergan-to-buy-medical-device-company-and-breast-surgery-funnel-maker-keller-medical-inc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.foxbusiness.com/markets/allergan-to-buy-medical-device-company-and-breast-surgery-funnel-maker-keller-medical-inc'" tppabs="https://www.foxbusiness.com/markets/allergan-to-buy-medical-device-company-and-breast-surgery-funnel-maker-keller-medical-inc" class="external text external">"Allergan To Buy Medical Device Company And Breast Surgery Funnel-maker Keller Medical Inc"</a>. <i>Fox Business - MarketWatch Pulse</i>. 2017-06-07<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/unique-allergan-swoops-in-and-bags-troubled-repros-therapeutics/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/unique-allergan-swoops-in-and-bags-troubled-repros-therapeutics/'" tppabs="https://www.biospace.com/article/unique-allergan-swoops-in-and-bags-troubled-repros-therapeutics/" class="external text external">"Allergan Swoops in and Bags Troubled Repros Therapeutics"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/am6a-botox-maker-allergan-buys-aesthetic-company-bonti-for-195-million-up-front/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/am6a-botox-maker-allergan-buys-aesthetic-company-bonti-for-195-million-up-front/'" tppabs="https://www.biospace.com/article/am6a-botox-maker-allergan-buys-aesthetic-company-bonti-for-195-million-up-front/" class="external text external">"Botox Maker Allergan Buys Aesthetic Company Bonti for $195 Million Up Front"</a>. <i>BioSpace</i>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline/'" tppabs="https://www.biospace.com/article/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline/" class="external text external">"Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline"</a>. <i>BioSpace</i>.</cite></span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.biospace.com/article/allergan-acquires-envy-medical-inc-adding-skin-resurfacing-dermalinfusion-system-to-best-in-class-medical-aesthetics-portfolio/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.biospace.com/article/allergan-acquires-envy-medical-inc-adding-skin-resurfacing-dermalinfusion-system-to-best-in-class-medical-aesthetics-portfolio/'" tppabs="https://www.biospace.com/article/allergan-acquires-envy-medical-inc-adding-skin-resurfacing-dermalinfusion-system-to-best-in-class-medical-aesthetics-portfolio/" class="external text external">"Allergan Acquires Envy Medical, Inc., Adding Skin Resurfacing Dermalinfusion System to Best-in-Class Medical Aesthetics Portfolio"</a>. <i>BioSpace</i>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fiercepharma.com/manufacturing/allergan-unveils-new-botox-plant-63b-abbvie-merger-edges-to-completion  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fiercepharma.com/manufacturing/allergan-unveils-new-botox-plant-63b-abbvie-merger-edges-to-completion'" tppabs="https://www.fiercepharma.com/manufacturing/allergan-unveils-new-botox-plant-63b-abbvie-merger-edges-to-completion" class="external text external">"Allergan unveils new Botox plant ahead of $63B AbbVie merger"</a>. <i>FiercePharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite id="CITEREFStempel2018" class="citation news cs1">Stempel, Jonathan (January 23, 2018). <a href="javascript:if(confirm('https://www.reuters.com/article/us-usa-opioids-litigation-newyorkcity/new-york-city-sues-drug-companies-over-opioid-epidemic-idUSKBN1FC2GK  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/us-usa-opioids-litigation-newyorkcity/new-york-city-sues-drug-companies-over-opioid-epidemic-idUSKBN1FC2GK'" tppabs="https://www.reuters.com/article/us-usa-opioids-litigation-newyorkcity/new-york-city-sues-drug-companies-over-opioid-epidemic-idUSKBN1FC2GK" class="external text external">"New York City sues drug companies over opioid epidemic"</a>. <i>Reuters</i>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite id="CITEREFGurmanMulvihill2018" class="citation news cs1">Gurman, Sadie; Mulvihill, Geoff (2 March 2018). <a href="javascript:if(confirm('https://www.dddmag.com/news/2018/03/doj-support-lawsuits-against-companies-selling-opioids  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.dddmag.com/news/2018/03/doj-support-lawsuits-against-companies-selling-opioids'" tppabs="https://www.dddmag.com/news/2018/03/doj-support-lawsuits-against-companies-selling-opioids" class="external text external">"DOJ to Support Lawsuits Against Companies Selling Opioids"</a>. <i>Drug Discovery &amp; Development</i>. Advantage Business Media. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">2 March</span> 2018</span>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite id="CITEREFBursztynsky2019" class="citation web cs1">Bursztynsky, Jessica (2019-12-26). <a href="javascript:if(confirm('https://www.cnbc.com/2019/12/26/migraine-sufferers-have-new-tool-with-approval-of-allergans-ubrelvy.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cnbc.com/2019/12/26/migraine-sufferers-have-new-tool-with-approval-of-allergans-ubrelvy.html'" tppabs="https://www.cnbc.com/2019/12/26/migraine-sufferers-have-new-tool-with-approval-of-allergans-ubrelvy.html" class="external text external">"Migraine sufferers have new oral medication with FDA approval of Allergan's Ubrelvy"</a>. <i>CNBC</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-08</span></span>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><span class="official-website"><span class="url"><a href="javascript:if(confirm('https://www.allergan.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.allergan.com/'" tppabs="https://www.allergan.com/" class="external text external">Official website</a></span></span><span> </span><figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></li></ul>
<span>
</span><ul><li><div class="hlist hlist-separated"><ul><li>Historical business data for Allergan plc: </li>
<li> <a href="javascript:if(confirm('https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=AGN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=AGN'" tppabs="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=AGN" class="external text external">SEC filings</a></li></ul></div></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Pharmaceutical_companies_of_the_United_States" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Pharmaceutical_companies_of_the_United_States" style="font-size:114%;margin:0 4em">Pharmaceutical companies of the United States</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Current</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abbott Laboratories</li>
<li>AbbVie Inc.</li>
<li>Acorda Therapeutics</li>
<li>Aderis</li>
<li>Advaxis</li>
<li>Alcon</li>
<li>Alexion</li>
<li>Alnylam</li>
<li>Amgen</li>
<li>Amneal Pharmaceuticals</li>
<li>Avax Technologies</li>
<li>Baxter</li>
<li>BioCryst</li>
<li>Biogen</li>
<li>Bioverativ</li>
<li>Biovest</li>
<li>Biovista</li>
<li>Bristol-Myers Squibb</li>
<li>Century</li>
<li>Ceragenix</li>
<li>Combe</li>
<li>CytoSport</li>
<li>CytRx</li>
<li>Danco Laboratories</li>
<li>Eli Lilly</li>
<li>Galena Biopharma</li>
<li>Genentech</li>
<li>Gilead Sciences</li>
<li>Ionis</li>
<li>Institute for OneWorld Health</li>
<li>Intercept</li>
<li>Johnson &amp; Johnson
<ul><li>Ethicon</li>
<li>Janssen Biotech</li>
<li>McNeil Consumer Healthcare</li>
<li>Ortho-McNeil</li></ul></li>
<li>Kinetic Concepts</li>
<li>McKesson</li>
<li>Melinta Therapeutics</li>
<li>Melior Discovery</li>
<li>Mentholatum</li>
<li>Merck &amp; Co.</li>
<li>Merrimack Pharmaceuticals</li>
<li>Myriad Genetics</li>
<li>Moderna</li>
<li>Northwest Biotherapeutics</li>
<li>Norwich Pharma</li>
<li>NovaBay</li>
<li>Ovation</li>
<li>Pfizer
<ul><li>Hospira</li>
<li>Searle</li></ul></li>
<li>Pharmaceutical Product Development</li>
<li>Prasco Laboratories</li>
<li>Procter &amp; Gamble</li>
<li>Proteon Therapeutics</li>
<li>Purdue Pharma</li>
<li>Quark</li>
<li>Regeneron</li>
<li>RespireRx</li>
<li>Sarepta Therapeutics</li>
<li>Sheffield</li>
<li>Spectrum</li>
<li>Tec Laboratories</li>
<li>Titan</li>
<li>Trevena Inc</li>
<li>Upsher-Smith</li>
<li>Ventria Bioscience</li>
<li>Vertex</li>
<li>West Pharmaceutical Services</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Former</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Irish tax inversion</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Actavis (2013)</li>
<li>Alkermes (2011)</li>
<li><a href="Allergan.htm" tppabs="https://ptable.com/wiki/compounds/A/Allergan" title="Allergan">Allergan</a> (2015)</li>
<li>Covidien (2007)</li>
<li>Endo International (2014)</li>
<li>Horizon Therapeutics (2014)</li>
<li>Jazz Pharmaceuticals (2012)</li>
<li>Mallinckrodt (2013)</li>
<li>Perrigo (2013)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other tax inversion</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bausch Health (Canada, 2010)</li>
<li>Mylan (Netherlands, 2015)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>ALZA</li>
<li>Allergan, Inc.</li>
<li>Amylin</li>
<li>ARIAD</li>
<li>Barr</li>
<li>Biolex</li>
<li>Bradley</li>
<li>CancerVax</li>
<li>Cephalon</li>
<li>CoTherix</li>
<li>Covance</li>
<li>Cubist</li>
<li>Cutter Laboratories</li>
<li>DNAPrint Genomics</li>
<li>Epix</li>
<li>Forest Laboratories</li>
<li>Genta</li>
<li>ImClone Systems</li>
<li>ISTA</li>
<li>King</li>
<li>KV</li>
<li>Leiner Health Products</li>
<li>Martek Biosciences</li>
<li>Massengill</li>
<li>Miles Laboratories</li>
<li>Naurex</li>
<li>Nereus</li>
<li>Nuvelo</li>
<li>Organon</li>
<li>Ortho</li>
<li>OSI</li>
<li>Parke-Davis</li>
<li>Repros Therapeutics</li>
<li>Qualitest</li>
<li>Rib-X</li>
<li>Schering-Plough</li>
<li>Smith, Kline &amp; French</li>
<li>Sterling Drug</li>
<li>Tanox</li>
<li>TAP</li>
<li>Trubion</li>
<li>Upjohn</li>
<li>Verus</li>
<li>Vion</li>
<li>ViroPharma</li>
<li>Wyeth</li>
<li>Zonite</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li>List of pharmaceutical companies</li></ul>
</div></td></tr></tbody></table></div>

<div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q906187&amp;#124;Edit_this_at_Wikidata" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th id="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q906187&amp;#124;Edit_this_at_Wikidata" scope="row" class="navbox-group" style="width:1%">Authority control <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="nowrap">ISNI: <span class="uid"><a href="javascript:if(confirm('http://isni.org/isni/0000000405684122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://isni.org/isni/0000000405684122'" tppabs="http://isni.org/isni/0000000405684122" class="external text external">0000 0004 0568 4122</a></span></span></li></ul>

</div></td></tr></tbody></table></div>










<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>